The University of Southampton
University of Southampton Institutional Repository

c‐myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours

c‐myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours
c‐myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours

c‐myc is a conserved cellular gene. The gene product is a nuclear‐bound 62000 molecular weight phosphoprotein (p62c‐myc). Although p62c‐myc levels have been measured in colorectal cancers, little is known about the expression of the protein in upper gastrointestinal tumours and tissues. Studies were performed on tumour and mucosal specimens from 87 patients with colorectal cancer, from two with polyposis coli, from six with squamous oesophageal carcinomas and from 18 with gastric carcinomas. The mean p62c‐myc content was measured in units of fluorescence in the G1 diploid and G2 diploid peaks of the cell cycle by multiparameter flow cytometry using the 6E10 antibody. The nuclear p62c‐myc content increased with DNA synthesis in tumours and mucosa. G2 levels of p62c‐myc were higher in glandular mucosa than in adenocarcinomas. No differences in peak nuclear c‐myc expression were found in relation to histological grade or to anatomical site of colorectal tumours. There was a broadly inverse relationship between G2 p62c‐myc levels in tumours and mucosa and their in vivo 5‐bromo‐2′‐deoxyuridine labelling indices. Nuclear p62c‐myc levels are cell cycle related but the protein has not been shown to be a marker of increased tissue proliferation or of gastrointestinal malignancy. The reduction of the nuclear p62c‐myc content of many adenocarcinoma cells compared with glandular mucosa cells suggests that reduced synthesis or nuclear retention of the normal protein may be a factor in the development of gastrointestinal adenocarcinomas, although the mechanism by which this may occur is not clear.

0007-1323
1080-1083
Rew, D. A.
36dcc3ad-2379-4b61-a468-5c623d796887
Taylor, I.
7d2e7ab1-3f64-4a90-8c21-440866514bc6
Cox, H.
966cc57d-c96b-4262-9270-a0b62a920c99
Watson, J. V.
72a50688-f0fb-41f6-a8ec-30605aeb279b
Wilson, G. D.
f988f5ba-4829-4e87-909d-d106a6f4ebce
Rew, D. A.
36dcc3ad-2379-4b61-a468-5c623d796887
Taylor, I.
7d2e7ab1-3f64-4a90-8c21-440866514bc6
Cox, H.
966cc57d-c96b-4262-9270-a0b62a920c99
Watson, J. V.
72a50688-f0fb-41f6-a8ec-30605aeb279b
Wilson, G. D.
f988f5ba-4829-4e87-909d-d106a6f4ebce

Rew, D. A., Taylor, I., Cox, H., Watson, J. V. and Wilson, G. D. (1991) c‐myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours. British Journal of Surgery, 78 (9), 1080-1083. (doi:10.1002/bjs.1800780916).

Record type: Article

Abstract

c‐myc is a conserved cellular gene. The gene product is a nuclear‐bound 62000 molecular weight phosphoprotein (p62c‐myc). Although p62c‐myc levels have been measured in colorectal cancers, little is known about the expression of the protein in upper gastrointestinal tumours and tissues. Studies were performed on tumour and mucosal specimens from 87 patients with colorectal cancer, from two with polyposis coli, from six with squamous oesophageal carcinomas and from 18 with gastric carcinomas. The mean p62c‐myc content was measured in units of fluorescence in the G1 diploid and G2 diploid peaks of the cell cycle by multiparameter flow cytometry using the 6E10 antibody. The nuclear p62c‐myc content increased with DNA synthesis in tumours and mucosa. G2 levels of p62c‐myc were higher in glandular mucosa than in adenocarcinomas. No differences in peak nuclear c‐myc expression were found in relation to histological grade or to anatomical site of colorectal tumours. There was a broadly inverse relationship between G2 p62c‐myc levels in tumours and mucosa and their in vivo 5‐bromo‐2′‐deoxyuridine labelling indices. Nuclear p62c‐myc levels are cell cycle related but the protein has not been shown to be a marker of increased tissue proliferation or of gastrointestinal malignancy. The reduction of the nuclear p62c‐myc content of many adenocarcinoma cells compared with glandular mucosa cells suggests that reduced synthesis or nuclear retention of the normal protein may be a factor in the development of gastrointestinal adenocarcinomas, although the mechanism by which this may occur is not clear.

This record has no associated files available for download.

More information

Published date: September 1991
Additional Information: Copyright: Copyright 2016 Elsevier B.V., All rights reserved.

Identifiers

Local EPrints ID: 447905
URI: http://eprints.soton.ac.uk/id/eprint/447905
ISSN: 0007-1323
PURE UUID: 5c867a3a-43e2-49d7-977b-3f1eaa6a2b79
ORCID for D. A. Rew: ORCID iD orcid.org/0000-0002-4518-2667

Catalogue record

Date deposited: 25 Mar 2021 18:29
Last modified: 17 Mar 2024 03:56

Export record

Altmetrics

Contributors

Author: D. A. Rew ORCID iD
Author: I. Taylor
Author: H. Cox
Author: J. V. Watson
Author: G. D. Wilson

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×